Patients by age, size and position of an aneurysm, complications, and follow-up
| No/Age (years)/Gender | Clinical presentation | Location | Type | Size (mm)/Neck (mm) | Dilatation of the stent with the PTA balloon | Late clinical complications | Type of control to confirm closure/Status (month) | OKM Scale |
|---|---|---|---|---|---|---|---|---|
| 1/57/Female | Mass effect (vision loss) | Parophthalmic | S | 12/5 | – | – | CTA/Complete (3) | C3 |
| 2/72/Female | Incidental (headache) | Parophthalmic | S | 7/5 | – | – | CTA/Complete (14) | A2 |
| 3/55/Female | Recurrent (coil) incidental (headache) | Parophthalmic | S | 5/3 | – | – | CTA/Complete (5) | B3 |
| 4/47/Female | Incidental (headache) | Petrous ICA | S | 4/4 | PTA | – | CTA/Complete (6) | B3 |
| 5/62/Female | Incidental (headache) | ICA – PCOM | S | 6/6 | – | – | CTA/Complete (2) | D |
| 6/57/Female | Mass effect (vision loss) | Carotidcavernous | S | 7/4 | – | – | CTA/Complete (1) | D |
| 7/56/Female | Mass effect (diplopia) | Parophthalmic | S | 12/7 | PTA | – | CTA/Complete (3) | C2 |
| 8/48/Female | Mass effect (diplopia) | Parophthalmic | S | 17/7 | – | Stent shortening | MRA/Complete (15) | A3 |
| 9/22/Female | Mass effect (diplopia) | Parophthalmic | F | 20/10 | – | – | MRA/Complete (6) | B2 |
| 10/52/Female | Mass effect (diplopia) | ICA – PCOM | S | 23/9 | – | – | MRA/Complete (6) | B3 |
| 11/52/Female | Mass effect (diplopia) | Parophthalmic | S | 20/3 | – | – | DSA/Complete (3) | C2 |
| 12/55/Female | Mass effect (diplopia) | Parophthalmic | S | 22/5 | PTA | – | MRA/Complete (6) | C1 |
| 13/47/Female | Incidental (headache) | ICA – PCOM | S | 4/3 | – | – | DSA/Complete (3) | C3 |
| 14/54/Male | Recurrent aneurysm (clip) (headache) | ICA – cisternal | F | 16/14 | – | – | MRA/Complete (6) | B2 |
| 15/28/Male | Incidental (headache) | M1 | S | 6/5 | – | – | MRA/Complete (6) | B3 |